Cultured keratinocytes in burn wound care: a non-randomised study

Queen Mary University London (UK)0 个研究点目标入组 10 人开始时间: 2012年6月25日最近更新: 2016年12月19日

适应症

试验速览

暂无简介。

•1. Patients who are 18 years old at least
•2. Patient is in good general health
•3. Patient is willing and able to co-operate with the protocol for the duration of the study
•4. Patients with a donor graft site due to requiring a split skin graft to treat a large burn
•5. Patients able to give written consent

•1. Patients unable to give written consent
•2. Terminally ill patients
•3. Pregnant women
•4. Patients with skin disorders that may affect the growth of cells or subsequent wound healing e.g. patients on high concentrations of steroids, patients with psoriasis or eczema
•6. Patient has a history of hypersensitivity to any components of either Cryoskin Spray (e.g. DMSO) or ReCell (trypsin)
•7. Patients with eczema; genetic skin conditions; hypertrophic or keloid scars

发起方

Queen Mary University London (UK)